Completed
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung
NCT01218516
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +8 more
- Locations
-
- Ironwood Cancer and Research Center Chandler, Arizona, United States
- Arizona Center for Hematology Oncology Glendale, Arizona, United States
- Providence Health System Beverly Hills, California, United States
- Cancer Care Associates of Fresno Medical Group, Inc. Fresno, California, United States